Jurgen Piek
Overview
Explore the profile of Jurgen Piek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plante M, Mahner S, Sebastianelli A, Bessette P, Lambaudie E, Guyon F, et al.
Int J Gynecol Cancer
. 2025 Jan;
35(1):100001.
PMID: 39878257
Objective: The Laparoscopic Approach to Cervical Cancer trial demonstrated that minimally invasive radical hysterectomy was associated with worse disease-free survival and overall survival among women with early-stage cervical cancer. It...
2.
Leijtens L, Piek J, Verrijssen A, Rijkaart D, Wortman B, Oele-Egelmeer A, et al.
Gynecol Oncol
. 2025 Jan;
193:41-48.
PMID: 39778332
Objective: To determine the incidence of clinical and subclinical venous thromboembolic events (VTE) in patients with locally advanced cervical cancer (LACC) treated with high-dose thromboprophylaxis during definitive chemoradiation and brachytherapy....
3.
van Kol K, Ebisch R, Beugeling M, Cnossen J, Nederend J, Hamont D, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201625
Objectives: There is no consensus on the most reliable procedure to determine remission of cervical cancer after chemoradiotherapy (CRT). Therefore, this study aims to assess the diagnostic performance of two...
4.
van Kol K, Ebisch R, Piek J, Beugeling M, Vergeldt T, Bekkers R
Cancers (Basel)
. 2021 Dec;
13(24).
PMID: 34944810
Objective: To determine the incidence of pathology-proven residual disease in adjuvant hysterectomy specimens in patients with cervical cancer, treated with chemoradiation therapy. Secondly, to assess a possible association for pathology-proven...
5.
van Lieshout L, van der Ploeg P, Wesseling-Rozendaal Y, van de Stolpe A, Bosch S, Lentjes-Beer M, et al.
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680250
High-grade serous ovarian carcinoma (HGSC), the most common subtype of ovarian cancer, has a high mortality rate. Although there are some factors associated with survival, such as stage of disease,...
6.
Roze J, Sendino Garvi E, Stelloo E, Stangl C, Sereno F, Duran K, et al.
Cancers (Basel)
. 2021 Jan;
13(3).
PMID: 33498451
Adult granulosa cell tumors (AGCTs) arise from the estrogen-producing granulosa cells. Treatment of recurrence remains a clinical challenge, as systemic anti-hormonal treatment or chemotherapy is only effective in selected patients....
7.
van Lieshout L, van de Stolpe A, van der Ploeg P, Bowtell D, de Hullu J, Piek J
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32961868
We investigated signal transduction pathway (STP) activity in high-grade serous ovarian carcinoma (HGSC) in relation to progression-free survival (PFS) and overall survival (OS). We made use of signal transduction pathway...
8.
Roze J, Monroe G, Kutzera J, Groeneweg J, Stelloo E, Paijens S, et al.
Cancers (Basel)
. 2020 May;
12(5).
PMID: 32455687
Adult granulosa cell tumors (AGCTs) harbor a somatic c.402C>G mutation in ~95% of cases and are mainly surgically removed due to limited systemic treatment effect. In this study, potentially targetable...
9.
Henker C, Hiepel M, Kriesen T, Scherer M, Glass A, Herold-Mende C, et al.
Acta Neurochir (Wien)
. 2019 Jun;
161(8):1723-1732.
PMID: 31254065
Background: The objective of this study was to evaluate the morphology of glioblastoma on structural pretreatment magnetic resonance imaging (MRI), defining imaging prognostic factors. Method: We conducted a retrospective analysis...
10.
Henker C, Kriesen T, Scherer M, Glass A, von Deimling A, Bendszus M, et al.
Neurosurgery
. 2019 Mar;
85(4):E722-E729.
PMID: 30888031
Background: Seizures are a common initial symptom of malignant brain tumors such as glioblastoma (GBM). However, why some of these tumors are epileptogenic and others never trigger seizures remains controversial....